In vitro evaluation of the astatinated chimeric monoclonal antibody U36, a potential candidate for treatment of head and neck squamous cell carcinoma.
about
Astatine Radiopharmaceuticals: Prospects and ProblemsAn overview of targeted alpha therapy.Targeted alpha-particle radiotherapy with 211At-labeled monoclonal antibodies.In vivo characterization of the novel CD44v6-targeting Fab fragment AbD15179 for molecular imaging of squamous cell carcinoma: a dual-isotope study.Radioimmunotherapy with astatine-211 using chimeric monoclonal antibody U36 in head and neck squamous cell carcinoma.CD44v6-Targeted Imaging of Head and Neck Squamous Cell Carcinoma: Antibody-Based Approaches.
P2860
In vitro evaluation of the astatinated chimeric monoclonal antibody U36, a potential candidate for treatment of head and neck squamous cell carcinoma.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
In vitro evaluation of the ast ...... neck squamous cell carcinoma.
@en
type
label
In vitro evaluation of the ast ...... neck squamous cell carcinoma.
@en
prefLabel
In vitro evaluation of the ast ...... neck squamous cell carcinoma.
@en
P2093
P2860
P1476
In vitro evaluation of the ast ...... neck squamous cell carcinoma.
@en
P2093
P2860
P2888
P304
P356
10.1007/S00259-005-1848-2
P577
2005-07-19T00:00:00Z